Sonoma Pharmaceuticals, Inc. — Director's Dealing 2017

Jun 1, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sonoma Pharmaceuticals, Inc. (SNOA)
CIK: 0001367083
Period of Report: 2017-05-30

Reporting Person: MCLAUGHLIN JOHN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-05-30	Common Stock, $0.0001 par value per share	A	1036	—	Acquired	12261	Direct

Footnotes

F1: The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan.